Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of ASP0456 for Irritable bowel syndrome with constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• ASP0456

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 3 | Status: COMPLETED